Get In Touch

GLOBAL VALUE DOSSIER BY NOVEL HEALTH STRATEGIES

Developing GVD for Pricing and Market Access Success

GVD is the single strategy document which summarizes all clinical, economic, quality of life, health outcomes and economic studies on a product and clearly communicates the payer value proposition story to all relevant stakeholders. Due to several recent market events, GVD has emerged as a powerful tool to present cost and comparative effectiveness data for medical products. Join us for a live webinar for discussion on the following topics:

How to prepare comprehensive, concise and clear GVD for drugs and devices?

Using HTAs as a valuable source for developing GVD
How to develop and communicate budget impact model and cost effectiveness analysis using GVD?
How to conduct thorough and complete systematic review for GVD?
How to demonstrate comparative effectiveness of your products using GVD
Strategies to include meta-analysis and indirect comparisons in the GVD
What strategies can be implemented to easily maintain and update GVD with latest clinical and health economic information?
What type of electronic tools (e-dossier, ipad etc) can be used to present GVD?
Key findings from Novel Health survey with public and private payer stakeholders for developing value proposition story
Lessons learned from Novel Health's experience of developing global value dossiers for some of the recently launched blockbusters

 

Event Completed. Request In-Person Replay

Quick Takeways Series on GVD:

 

Five Commonly Made Mistakes While Developing Global Value Dossiers: Lessons Learned and Quick Takeaways


Top Strategy Mishaps of 2011-2012

NOVEL's team analyzed all product launches of 2011 and 2012 and developed a list of top strategy mishaps. This report also presents the lessons learned and implications for future products.

Read More

HEOR, Pricing and Marketing Strategy for Cancer Therapies

Oncology is the highest selling indication for pharmaceutical products. In a recent event NOVEL's team discussed the 10-years trends in oncology drug development.

Read More

Developing GVD for Pricing & Market Access Success

GVD is the single and central strategy resource for pricing and reimbursement of medical products. NOVEL's team recently hosted a webinar on strategies for developing GVDs.

Read More

Economic Models for HTAs, Payers and Providers

Economic models are becoming important tools for demonstrating economic value of new products. In our recent event we presented fundamentals of developing models, interactive design and easy-to-update features.

Read More